Transference-focused psychotherapy for borderline personality disorder. A study with female patients;Psicoterapia focalizada en la transferencia para el trastorno límite de la personalidad. Un estudio con pacientes femeninas

Salud Mental

Volumn 27, Issue 4, 2004, Pages 44-54

  López, David ^a   Cuevas, Pablo ^a   Gómez, Araceli ^b   Mendoza, Josefina ^a  

^a Grupo Invest Sobre Pacientes L   (Mexico)

^b UNIVERSIDAD ANÁHUAC   (Mexico)

Author keywords

Borderline personality disorder; Clinical trial; Transference Focused Psychotherapy

Indexed keywords

FLUVOXAMINE; OLANZAPINE; OMEGA 3 FATTY ACID; VALPROIC ACID;

ADULT; ANTISOCIAL BEHAVIOR; ARTICLE; BIPOLAR DISORDER; BORDERLINE STATE; CLINICAL ARTICLE; COMORBIDITY; DELUSIONAL DISORDER; FAMILY THERAPY; FEMALE; GROUP THERAPY; HOSPITALIZATION; HUMAN; MENTAL DISEASE; PATIENT SELECTION; PSYCHODYNAMICS; PSYCHOTHERAPIST; PSYCHOTHERAPY; SUBSTANCE ABUSE; SUICIDE; TREATMENT OUTCOME;

EID: 7244242693     PISSN: 01853325     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. a Edición. Ed. Massen. Barcelona, 1994
2. BATEMAN A, FONAGY P: Effectiveness of partial hospitalization in the treatment of borderline personality disorder: A randomized controlled trial. Am J Psychiatry, 156:1563-1569, 1999.
3. BATEMAN A, FONAGY P: Health service utilization cost for borderline personality disorder patients treated with psychoanalytically oriented partial hospitalization versus general psychiatric care. Am J Psychiatry, 160:169-171, 2003
4. CLARKIN J, YEOMANS F, KERNBERG O: Psychotherapy for Borderline Personality. Wiley, Nueva York, 1999.
5. CLARKIN J, FOELSCH P, LEVY K, HULL J, DELANEY J, KERNBERG O: The development of a psychodynamic treatment for patients with borderline personality disorder: a preliminary study of behavioral change. J Personality Disorders, 15(6):487-495, 2001.
6. CUEVAS P, CAMACHO J, MEJIA R, ROSARIO I, PARRES R, MENDOZA J, LOPEZ D: Cambios en la psicopatología del trastorno límite de la personalidad con psicoterapia psicodinámica. Salud Mental, 23(6):1-11, 2000.
7. FIRST M, SPITZER R, GIBBON M, WILLIAMS J: Entrevista Clínica Estructurada para los Trastornos del Eje I del DSM-V. Masson, Barcelona, 1999.
8. FIRST M, GIBBON M, SPITZER R, WILLIAMS J, BENJAMIN L: Entrevista Clínica Estructurada para los Trastornos de Personalidad del Eje II del DSM-V. Masson, Barcelona, 1999.
9. GUNDERSON J, FRANK A, RONNINGSTAM E, WACHTER S, LYNCH V, WOLF P: Early discontinuance of borderline patients from psychotherapy. J Nerv Ment Dis, 177:38-42, 1989.
10. GUNDERSON JG, BERKOWITZ C, RUIZ-SANCHO A: Families of borderline patients: a psychoeducational approach. Bull Menninger Clin, 61:446-457, 1997.
11. HALL J, CALEO S, STEVENSON J, MEARES R: An economic analysis of psychotherapy for borderline personality disorder patients. J Ment Health Policy Econ, (1):3-8, 2001.
12. HOLLANDER E, ALLEN A, LOPEZ RP, BIENSTOCK CA, GROSSMAN R, SIEVER LJ, MERKATZ L, STEIN DJ: A preliminary double-blind, placebo-controlled trial of divalproex sodium in borderline personality disorder. J Clin Psychiatry, 62(3):199-203, 2001.
13. KERNBERG O: Psychoanalytic theory of personality disorders. En: Major Theories of Personality Disorders. Clarkin J, Lenzenweger M (eds.). Guilford Press, Nueva York, 1996.
14. LINEHAN MM: Cognitive-Behavioral Treatment of Borderline Personality Disorder. Guilford Press, Nueva York, 1993.
15. LINEHAN M, ARMSTRONG H, SUAREZ A, ALMON D, HEARD H: Cognitive-behavioral treatment of chronically parasuicidal borderline patients. Arch Gen Psychiatry, 48:1060-1064, 1991.
16. MUNROE-BLUM H, MARZIALI E: Time-limited group psychotherapy for borderline patients. Can J Psychiatry, 33:364-369, 1988.
17. RINNE T, VAN DEN BRINK W, WOUTERS L, VAN DYCK R: SSRI Treatment of borderline personality disorder: a randomized, placebo-controlled clinical trial for female patients with borderline personality disorder. Am J Psychiatry, 159:2048-2054, 2002.
18. SCHMITZ N, HARTKAMP N, FRANKE GH: Assessing clinically significant change: application to the SCL-90-R. Psychol Rep, 86(1):263-74, 2000.
19. STEVENSON J; MEARES R: An Outcome Study Of Psychotherapy For Patients With Borderline Personality Disorders. Am J Psychiatry, 149:358-362, 1992.
20. STARTUP M, JACKSON MC, BENDIX S: The concurrent validity of the Global Assessment of Functioning (GAF). Br J Clin Psychol, 41(Pt 4):417-22, 2002.
21. STONE M: Long-term outcome in personality disorders. British J Psychiatry, 162:299-313, 1993.
22. WALDINGER RJ, GUNDERSON JG: Effective Psychotherapy With Borderline Patients. American Psychiatric Press, Washington, 1989.
23. WEISSMAN MM: The epidemiology of personality disorders: a 1990 update. J Personality Disorders, 7:44-62, 1993.
24. ZANARINI M, FRANCKENBURG F, DUVO ED, SICKEL A, TRICKHA A, LEVIN A, REYNOLDS V: Axis I comorbidity of borderline personality disorder. Am J Psychiatry, 155:1733-1739, 1998.
25. ZANARINI MC, FRANKENBURG FR: Olanzapine treatment of female borderline personality disorder patients: a double blind, placebo controlled study. J Clin Psychiatry, 62(11):849-54, 2001.
26. ZANARINI MC, FRANKENBURG FR: Omega-3 fatty acid treatment of women with borderline personality disorder: a double-blind, placebo-controlled study. Am J Psychiatry, 160:167-169, 2003.